Cancer patients can respond very differently to the same treatment, while current testing may not reliably identify the therapy most likely to work for each tumor.
R&D Focus
AI driven personalised cancer treatment
Innovative Solution
Oxford Onco-Therapeutics is a personalized medicine startup that enables oncologists to predict the right treatment for each patient’s specific cancer using a data-driven approach.
Investment Funding
Revenue
$10M to $50M
People
Founders
Ashwin Nandakumar
About
Oxford Onco-Therapeutics is a personalized medicine startup that enables oncologists to predict the right treatment for each patient’s specific cancer using a data-driven approach.
Something missing or incorrect on this page? Help us enrich this information
